Physician profile

Randy K Kaplan

Podiatrist · West Bloomfield, MI

NPI 1649256991

$8,413.56

in general payments reported to CMS, 2019-2025

39 companies · $3,193 in 2025

The $3,193 reported for 2025 was more than what 94% of Podiatrist providers received nationally (typical 2025 total: $260).

See the full distribution for Podiatrist

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$4,484.25
Travel and Lodging$1,366.01
Education$678.20

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Ets Wound Care LLC $2,361.98 2025 Mirragen Advanced Wound Matrix
Aroa Biosurgery Incorporated $713.39 2022-2025
Organogenesis INC. $625.75 2021-2025 Puraply, Puraply Antimicrobial, Affinity
Nevro Corp. $446.04 2022-2024 Senza
Smith+Nephew, INC. $445.84 2022-2024 Renasys Touch, Pico 7, Grafix Pl
Depuy Synthes Sales INC. $357.73 2019-2025 Motoband, Minibunion, Motoband Cp
Treace Medical Concepts, INC. $325.03 2024-2025
Stryker Corporation $312.70 2019-2023 Phalinx
Kci USA, INC. $290.62 2020-2023 Activ.A.C., Promogran Prisma, V.A.C.Instill
Convatec INC. $289.41 2023-2025
Abbvie INC. $259.72 2024
Kerecis Limited $256.98 2023-2025 Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose
Paragon 28, INC. $241.80 2019-2025 Bun-Yo-Matic, Apex 3d
Inari Medical, INC. $226.77 2023 Flowtriever Catheter, S, Ct Thrombectomy System Kit
Solventum Corporation $148.04 2024-2025 Activ.A.C., V.A.C.Instill
Show all 39 companies
CompanyGeneral paymentsYearsTop products
Integra Lifesciences Corporation $138.77 2019-2022
Paratek Pharmaceuticals, INC. $134.16 2021-2025 Nuzyra
Medline Industries LP $132.63 2024
Arteriocyte Medical Systems, INC. $103.24 2019
Musculoskeletal Transplant Foundation INC. $96.20 2019
Misonix INC $79.34 2019
Ortho Dermatologics, A Division of Bausch Health US, LLC $55.02 2020-2023 Jublia
Heron Therapeutics, INC. $42.52 2022
Horizon Therapeutics Plc $38.94 2019-2021
Grt US Holding, INC. $38.27 2020-2022
Acera Surgical, INC. $33.13 2025 Restrata Wound Matrix
Zimmer Biomet Holdings, INC. $23.85 2020
Amgen INC. $22.96 2025 Krystexxa
Hartmann USA, INC. $21.67 2023 Zetuvit Plus
Acell, INC. $18.81 2019
Tactile Systems Technology INC $18.10 2024 Flexitouch Plus, Entre Plus
Pinnacle, INC $17.10 2025
Bioventus LLC $16.61 2020
Orthofix Medical, INC. $15.46 2024 Physio-Stim
Cashflow Solutions, LLC $14.60 2024 Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White
Next Science LLC $14.18 2023 Blastx, Xperience, Surgx
Kowa Pharmaceuticals America, INC. $12.63 2022
Melinta Therapeutics, LLC $12.38 2019
Bard Peripheral Vascular, INC. $11.19 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Randy K Kaplan

$8,413.56

in general payments reported 2019-2025

Years
2019-2025
Top company
Ets Wound Care LLC
Context
The $3,193 reported for 2025 was more than what 94% of Podiatrist providers received nationally (typical 2025 total: $260).

https://glasscript.com/doctor/74618/randy-k-kaplan

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.